To date, we have performed zero-ischemia RPN and LPN in more than 100 patients, including those with all types of challenging tumors. As a result of our growing experience, we now offer zero-ischemia RPN and LPN to virtually all comers, regardless of tumor location or renovascular anatomy.
Targeted radiation plus systemic therapy combo shows promise in mHSPC
March 18th 2024"The combination of highly potent systemic therapy and targeted radiation has shown impressive results in maintaining low PSA levels after testosterone recovery, offering hope for improved outcomes in these patients, but further studies are still needed to determine the best regimen," says Amar U. Kishan, MD.